A settlement was reached with the defendants in the lawsuit filed on behalf of certain investors of Marrone Bio Innovations Inc (NASDAQ:MBII) over alleged securities laws violations and a deadline to submit the settlement claim is upcoming on October 2, 2016 and NASDAQ:MBII investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 09/26/2016 -- The Shareholders Foundation announced that a deadline is coming up on October 2, 2016 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Marrone Bio Innovations Inc (NASDAQ:MBII) between August 1, 2013 and November 10, 2015.
Investors who purchased a significant amount of shares of Marrone Bio Innovations Inc (NASDAQ:MBII) between August 1, 2013 and November 10, 2015, have certain options and should contact the Shareholders Foundation by email at mail@shareholdersfoundation.com or call 858-779-1554.
The settlement proof of claim form or detailed settlement notice for the settlement in the Marrone Bio Innovations Inc (NASDAQ:MBII) Investor Securities Class Action Lawsuit can be downloaded at: http://shareholdersfoundation.com/case/marrone-bio-innovations-inc-nasdaq-mbii-investor-securities-class-action-lawsuit-09052014
In order to submit a claim an investor has to submit the claim proof to the class action claim administrator in a timely manner. The deadline to submit the proof with the class administrator is October 2, 2016. The class action administrator for this case is Garden City Group LLC.
The lawsuit was originally filed in the U.S. District Court for the Eastern District of California against Marrone Bio Innovations Inc over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between March 6, 2014 and September 2, 2014.
According to the complaint the plaintiff alleges on behalf of purchasers of Marrone Bio Innovations Inc (NASDAQ:MBII) common shares between March 6, 2014 and September 2, 2014, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that Defendants made allegedly false and/or misleading statements and/or failed to disclose that Marrone Bio Innovations Inc's financial statements contained errors related to the improper recognition of revenues, that Marrone Bio Innovations Inc lacked adequate internal controls over financial reporting, and that as a result of the foregoing, Marrone Bio Innovations Inc's financial statements were allegedly materially false and misleading at all relevant times.
Those who purchased shares of Marrone Bio Innovations Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com